Oliver Simon
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world assessment of low-density lipoprotein cholesterol goal, disease burden and financial burden among patients with atherosclerotic cardiovascular disease in Singapore-A single-centre retrospective cohort study.
Journal: Frontiers in cardiovascular medicine
Published: February 23, 2026
Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease.
Journal: Therapeutic advances in cardiovascular disease
Published: December 12, 2024
Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore.
Journal: Frontiers in cardiovascular medicine
Published: November 13, 2024
Atherosclerotic cardiovascular disease landscape in Singapore.
Journal: Frontiers in cardiovascular medicine
Published: November 22, 2023
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.
Journal: Journal of medicinal chemistry
Published: March 01, 2022
Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease reports
Published: March 25, 2020
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.
Journal: Science translational medicine
Published: February 28, 2020
Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hit.
Journal: Bioorganic & medicinal chemistry letters
Published: January 10, 2017
PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.
Journal: Antimicrobial agents and chemotherapy
Published: January 04, 2016
Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 21, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026